Trial intelligence / Profile preview

Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in a Resource-Limited Country

TCTR20220131001Completed

Sponsor
NA
Start
Sep 2019
Countries
1
01

Overview

Open-label trial in non-small cell lung cancer (NSCLC), sponsored by NA. Started Sep 2019; status: completed.

02

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on TCTR20220131001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220131001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call